Medical Expert Office – Leadership
HEAD OF DIVISION
Annastasiah Mudiwa Mhaka, PhD, Vice President of Strategic Alliances Development, and former Director of Life Sciences, Business Development & Strategic Alliances, at Johns Hopkins Medicine, is adept at working closely with key leadership in identifying and developing external partnerships that maximize the benefit and impact for ClinicalRM. While at Johns Hopkins, she led business development efforts in collaboration with IMEC, a world-renowned Belgian nanoelectronics research institute, which led to the execution of a multi-million dollar deal to fund an R&D program to develop a disposable point-of-need diagnostics platform that will revolutionize the way in which we manage our health. Prior to her role at Johns Hopkins, Dr. Mhaka worked at Booz & Company and Acidophil driving technical innovation through developing creative partnerships, solutions and strategies to overcome challenges in healthcare. Dr. Mhaka received a BS in Chemistry from the University of Pittsburgh and a PhD in Cellular and Molecular Medicine at Johns Hopkins where she discovered novel therapeutics for cancer.
SELECT EXPERTS AT A GLANCE
Mac Griffiss, MD, Senior Scientific Advisor, is a board certified internal medicine and infectious disease physician. He is also a renowned leader in infectious disease research of various diseases, with over 40 years in clinical expertise. Dr. Griffiss has extensive experience in laboratory experimentation, conduct of field trials, and recruitment and testing of individuals in a clinical setting.
David Hoover, MD, Senior Scientific Advisor, is a board-certified infectious disease physician with over 30 years of experience in preclinical and clinical research, including previous head of the U.S. Army Brucellosis Preclinical Vaccine Program. Dr. Hoover leads ClinicalRM’s CRO services infectious disease efforts and is a retired US Army Medical Corps officer, familiar with medical countermeasure product development, and serves as scientific and medical lead for ClinicalRM’s Ebola research efforts.
Stacey Trzcinski, MD, Medical Advisor at ClinicalRM, is a board certified pediatrician with over 5 years of clinical practice in pediatric hospitalist medicine, including previous positions held at Columbia-New York Presbyterian and New York University Langone Medical Center. Prior to joining ClinicalRM, Dr. Trzcinski’s clinical research concentrated in pediatric orthopedic medicine, pediatric neurology, and tropical medicine. She has spent a considerable amount of time in Guyana and Haiti as visiting medical faculty.
Amos Ndhere, MD, Principal Investigator at ACE Research, is a board-certified physician with over 10 years of experience in clinical and public health practice in Africa. Dr. Ndhere has been closely involved with clinical care and public health programs regarding multiple diseases incing HIV, malaria, and tuberculosis. He also serves as an Adjunct Instructor in Family and Community Medicine at Northwestern University in Chicago, IL.
Bernhards Ogutu, MD, Principal Investigator at ACE Research, is a board-certified Kenyan Pediatrician and Medical Practitioner, Clinical Pharmacologist, and Chief Research Officer with the Kenya Medical Research Institute (KEMRI). Dr. Ogutu has over 20 years of clinical trial development and disease pathogenesis expertise.
Leslie Lobel, MD, PhD, Senior Medical Advisor, is a member of the Department of Microbiology, Immunology and Genetics in the Faculty of Health Sciences at Ben Gurion University. In addition, he is a member of the Department of Emerging and Reemerging diseases and Special Pathogens at the Uganda Virus Research Institute (UVRI) in Entebbe, Uganda. Dr. Lobel’s work includes studies on the profile of the immune response to various viral diseases including Ebola Virus and Marburg Virus, CCHF, Foot and Mouth Disease Virus, and Arboviruses including the Flaviviruses and Zika. Dr. Lobel has been developing viruses as antiviral agents and is very well known for his non-standard way of solving scientific enigmas and for developing new methodologies. He has established strategic collaborations with the Gorgas Institute in Panama, Evandro Chagas Institute in Belem, Brazil and Fiocruz Institute in Salvador, Bahia, Brazil for studies of the immune response to Zika virus in different cohorts and populations of patients for vaccine development.
Jere Boyer, PhD, Senior Scientific Advisor, is an expert in biomedical science, immunology, and clinical microbiology, with over 30 years of experience. Dr. Boyer is an adjunct Professor of Microbiology and Immunology, as well as Clinical Professor in Public Health and Community Health Sciences at the Northeastern Ohio Medical University. He is board-certified in microbiology, as well as certified in human subjects’ protection in research.
Kevin Gilligan, PhD, Senior Scientific Advisor, is a virologist and emerging disease expert with over 30 years of experience in academia, government and industry developing vaccines, drugs and diagnostics to address public health issues related to global emerging disease. Dr. Gilligan joins ClinicalRM from HHS/BARDA (U.S. Department of Health and Human Services/Biomedical Advanced Research and Development Authority), where he focused on developing drugs and diagnostics for pandemic influenza.